Exceptional credentials across target classes, with a strong track record. Our extensive range of equipment enables us to develop assays for hit identification, mechanistic profiling and to support medicinal chemistry programmes, including more novel and challenging examples.
"We have worked with BioAscent for over a year now on a ligand finding project and are extremely pleased with this working relationship, encompassing fragment screening, synthetic chemistry and biophysical methodology. The teams are incredibly agile, amenable and responsive, and the data are very high quality and robust. On top of this the communication is very open and there is a genuine feeling that BioAscent are really invested in our success and the success of the project I lead. I would highly recommend BioAscent and they are a pleasure to work with."
Hayley Saunders, Project Leader at LifeArc
"Our target and mechanism was challenging (an allosteric, covalent inhibitor approach). The proposal from the BioAscent team to support our project was detailed and well-thought-out… The project itself really benefited from BioAscent’s biology and chemistry expertise, and the collaborative and open approach that they have – they were happy to listen to our ideas, while at the same time not afraid to challenge and contribute – I really appreciated this attitude."
Project Manager, Apollo Therapeutics
BioAscent scientists have extensive drug discovery expertise, utilising a wide range of technologies to design robust assays and deliver confident hit identification and mechanistic insights to accelerate decision making. With a proven track record from target validation through to candidate optimisation, BioAscent provides a uniquely comprehensive, flexible, and science led approach to even the most challenging targets.
